• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多巴胺DA1受体激动剂YM435在犬缺血性急性肾衰竭模型中的作用

Effect of YM435, a dopamine DA1 receptor agonist, in a canine model of ischemic acute renal failure.

作者信息

Yatsu T, Arai Y, Takizawa K, Kasai-Nakagawa C, Takanashi M, Uchida W, Inagaki O, Tanaka A, Takenaka T

机构信息

Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.

出版信息

Gen Pharmacol. 1998 Nov;31(5):803-7. doi: 10.1016/s0306-3623(98)00085-8.

DOI:10.1016/s0306-3623(98)00085-8
PMID:9809482
Abstract
  1. The effects of (-)-(S)-4-(3,4-dihydroxyphenyl)- 1,2,3,4-tetrahydroisoquinoline-7,8-diol monohydrochloride monohydrate (YM435), a dopamine DA1 receptor agonist, were evaluated in a canine model of ischemic acute renal failure (ARF). 2. ARF was induced by clamping the left renal artery for 1 hr and subsequent reperfusion of the left kidney in anesthetized uninephrectomized dogs. 3. After 1-hr complete renal artery occlusion, an intravenous infusion of either YM435 (0.3 microg/kg/ min) or 0.9% saline (vehicle) was begun and continued for 1 hr. 4. In the vehicle group, renal ischemia markedly decreased glomerular filtration rate, urine flow and urinary sodium excretion. The YM435 group was characterized by significant recoveries in glomerular filtration rate, urine flow, and urinary sodium excretion as compared with the vehicle group. 5. These results indicate that YM435 can facilitate recovery in glomerular filtration rate, urine flow, and urinary sodium excretion in a canine model of ARF induced by ischemia. YM435 may be useful in the preservation of renal function in ischemia-induced ARF.
摘要
  1. 评估了多巴胺DA1受体激动剂(-)-(S)-4-(3,4-二羟基苯基)-1,2,3,4-四氢异喹啉-7,8-二醇单盐酸盐一水合物(YM435)在犬缺血性急性肾衰竭(ARF)模型中的作用。2. 通过钳夹麻醉的单侧肾切除犬的左肾动脉1小时,随后对左肾进行再灌注来诱导ARF。3. 在肾动脉完全闭塞1小时后,开始静脉输注YM435(0.3微克/千克/分钟)或0.9%生理盐水(载体),并持续1小时。4. 在载体组中,肾缺血显著降低了肾小球滤过率、尿流和尿钠排泄。与载体组相比,YM435组的特点是肾小球滤过率、尿流和尿钠排泄有显著恢复。5. 这些结果表明,YM435可以促进缺血诱导的犬ARF模型中肾小球滤过率、尿流和尿钠排泄的恢复。YM435可能有助于缺血性ARF的肾功能保护。

相似文献

1
Effect of YM435, a dopamine DA1 receptor agonist, in a canine model of ischemic acute renal failure.多巴胺DA1受体激动剂YM435在犬缺血性急性肾衰竭模型中的作用
Gen Pharmacol. 1998 Nov;31(5):803-7. doi: 10.1016/s0306-3623(98)00085-8.
2
Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.新型多巴胺 D1 受体激动剂 YM435 对麻醉犬的肾脏影响
Eur J Pharmacol. 1997 Mar 12;322(1):45-53. doi: 10.1016/s0014-2999(96)00980-6.
3
Hemodynamic characterization of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs.新型多巴胺DA1受体激动剂YM435在麻醉犬体内的血流动力学特征
J Cardiovasc Pharmacol. 1997 Mar;29(3):382-8. doi: 10.1097/00005344-199703000-00012.
4
Effect of YM435, a novel dopamine DA1 receptor agonist, in a canine model of acute congestive heart failure.新型多巴胺DA1受体激动剂YM435在犬急性充血性心力衰竭模型中的作用
Gen Pharmacol. 1998 May;30(5):733-7. doi: 10.1016/s0306-3623(97)00340-6.
5
Pharmacological and pharmacokinetic characteristics of YM435, a novel dopamine DA1-receptor agonist, in anaesthetized dogs.新型多巴胺DA1受体激动剂YM435在麻醉犬体内的药理和药代动力学特性
J Pharm Pharmacol. 1997 Sep;49(9):892-6. doi: 10.1111/j.2042-7158.1997.tb06131.x.
6
Dopamine DA1 receptor agonist activity of YM435 in the canine renal vasculature.YM435在犬肾血管系统中的多巴胺DA1受体激动剂活性。
Gen Pharmacol. 1997 Aug;29(2):229-32. doi: 10.1016/s0306-3623(96)00402-8.
7
4-(3,4-Dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives. II. Their renal vasodilation activity and structure-activity relationship.4-(3,4-二羟基苯基)-1,2,3,4-四氢异喹啉衍生物。II. 它们的肾血管舒张活性及构效关系。
Chem Pharm Bull (Tokyo). 1996 Oct;44(10):1865-70. doi: 10.1248/cpb.44.1865.
8
Synthesis, resolution, and renal vasodilation activity of novel DA1 agonists: 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives.新型DA1激动剂:4-(3,4-二羟基苯基)-1,2,3,4-四氢异喹啉衍生物的合成、拆分及肾血管舒张活性
Chem Pharm Bull (Tokyo). 1991 Nov;39(11):2910-4. doi: 10.1248/cpb.39.2910.
9
Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435.新型多巴胺能(DA1)激动剂YM435的肾微血管作用特性
J Pharmacol Exp Ther. 1993 Mar;264(3):1154-9.
10
Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats.多巴胺D-1激动剂非诺多泮和钙通道拮抗剂氯维地平对麻醉大鼠急性肾衰竭的影响。
Clin Exp Hypertens. 2002 May;24(4):301-13. doi: 10.1081/ceh-120004233.

引用本文的文献

1
Aggregability of the SQSTM1/p62-based aggresome-like induced structures determines the sensitivity to parthanatos.基于SQSTM1/p62的聚集体样诱导结构的聚集性决定了对PARP-1依赖性细胞死亡的敏感性。
Cell Death Discov. 2024 Feb 12;10(1):74. doi: 10.1038/s41420-024-01838-2.
2
Catheter-based induction of renal ischemia/reperfusion in swine: description of an experimental model.基于导管的猪肾缺血/再灌注诱导:一种实验模型的描述。
Physiol Rep. 2014 Sep 28;2(9). doi: 10.14814/phy2.12150. Print 2014 Sep 1.